×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
AACR Annual Meeting 2018 - Palforzia, Aimmune Therapeutics
The Pharma Letter
Phase III data shows meaningful desensitization by Aimmune's Palforzia. 17-02-2022. USA-based biotech Aimmune Therapeutics, which is now fully owned by...
20 hours ago
Palforzia gets new owner as Nestlé ditches peanut allergy drug
Fierce Pharma
Nestlé has resold the peanut allergy drug Palforzia, which it originally bought in 2020 in a $2 billion-plus acquisition.
8 months ago
Nestle's Dud With Peanut-Allergy Business Carries Lessons
Bloomberg.com
The Swiss confectioner has finally achieved an exit from its purchase of a biotech focused on alleviating peanut allergy.
8 months ago
Nestlé Sells Peanut Allergy Drug, Ending the Food Giant’s Foray Into Biotech
MedCity News
Peanut allergy ranks among the most common of food allergies, so Nestlé hoped that adding the first FDA-approved peanut allergy product to...
8 months ago
AACR Annual Meeting 2018 - Palforzia, Desensitization
The Pharma Letter
Phase III data shows meaningful desensitization by Aimmune's Palforzia. 17-02-2022. USA-based biotech Aimmune Therapeutics, which is now fully owned by...
20 hours ago
Nestle divests peanut allergy business Palforzia
Reuters
Nestle has divested its peanut allergy treatment business Palforzia, the Swiss food company said on Monday, following its strategic review...
8 months ago
Nestlé divests peanut allergy treatment Palforzia to Stallergenes Greer
Pharmaceutical Technology
Nestlé has sold its peanut allergy drug Palforzia to Swiss biopharma Stallergenes Greer harma, concluding a year-long strategic review.
8 months ago
Allergy Immunotherapy Soars: Anticipating a $2.69 Billion Market by 2028 with an Impressive CAGR of 8.12%
Yahoo Finance
Global Allergy Immunotherapy Market Global Allergy Immunotherapy Market Dublin, Feb. 05, 2024 (GLOBE NEWSWIRE) -- The "Global Allergy...
3 months ago
Peanut Allergy Market to Accelerate Substantially by 2032, Examines DelveInsight | Leading Companies - Vedanta ...
GlobeNewswire
The dynamics of the peanut allergy market are anticipated to change in the coming years owing to the improvement in the diagnosis...
7 months ago
Nestle pays $2 billion to secure Aimmune's allergy treatment
CNBC
Nestle plans to pay $2 billion to gain full ownership of peanut allergy treatment maker Aimmune Therapeutics, as the Swiss company expands...
44 months ago